These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16999237)

  • 1. [Case report article: ovulation and Diane-35, current perspectives in detection and control of fertility].
    Murcia JM; Esparza ML
    Rev Med Univ Navarra; 2006; 50(2):26-9. PubMed ID: 16999237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of Microgynon and Diane-35, two sub-fifty ovulation inhibitors, on voice function in women.
    Wendler J; Siegert C; Schelhorn P; Klinger G; Gurr S; Kaufmann J; Aydinlik S; Braunschweig T
    Contraception; 1995 Dec; 52(6):343-8. PubMed ID: 8749597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
    Zhang S; Tu H; Yao J; Le J; Jiang Z; Tang Q; Zhang R; Huo P; Lei X
    Reprod Biol Endocrinol; 2020 Jun; 18(1):58. PubMed ID: 32493421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
    Brzezińska-Wcisło L
    Wiad Lek; 2003; 56(3-4):202-5. PubMed ID: 12923971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
    Luboshitzky R; Herer P; Shen-Orr Z
    Neuro Endocrinol Lett; 2002 Aug; 23(4):309-13. PubMed ID: 12195232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary.
    Vrbikova J; Dvorakova K; Hill M; Starka L
    Endocr Regul; 2006 Dec; 40(4):119-23. PubMed ID: 17201585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diane].
    Hansted B; Reymann F
    Ugeskr Laeger; 1983 Aug; 145(31):2391-2. PubMed ID: 6623686
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiandrogens in female androgenetic alopecia].
    Winkler K
    Hautarzt; 1972 Nov; 23(11):518-9. PubMed ID: 4647431
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiology of ovulation and mode of action of contraceptive pills].
    Christin-Maitre S
    Rev Prat; 2008 Jan; 58(1):17-20. PubMed ID: 18326357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of an anti-androgen combination preparation on the hemostatic system].
    Bruni V; Rosati D; Bucciantini S; Verni A; Abbate R; Pinto S; Costanzo G; Costanzo M
    Fortschr Med; 1987 Jan; 105(3):55-8. PubMed ID: 3557259
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
    Luque-Ramírez M; Alvarez-Blasco F; Botella-Carretero JI; Sanchón R; San Millán JL; Escobar-Morreale HF
    Diabetes Care; 2007 Sep; 30(9):2309-13. PubMed ID: 17536071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of oxidative stress to PCOS].
    Zhang D; Luo WY; Liao H; Wang CF; Sun Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):421-3. PubMed ID: 18575330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma ghrelin concentrations in patients with polycystic ovary syndrome before and after 6months therapy: correlation with androgen levels.
    Kos-Kudła B; Małecka-Mikosz O; Foltyn W; Ostrowska Z; Kudła M; Mazur B
    Neuro Endocrinol Lett; 2006 Dec; 27(6):763-7. PubMed ID: 17187005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of hormonal therapy for female pattern (androgenic) alopecia.
    Scheinfeld N
    Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
    Luque-Ramírez M; Alvarez-Blasco F; Uriol Rivera MG; Escobar-Morreale HF
    Hum Reprod; 2008 Jul; 23(7):1594-601. PubMed ID: 18375410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scrutiny of Diane-35 due to potential dangers of off-label prescribing.
    Collier R
    CMAJ; 2013 Mar; 185(5):E217-8. PubMed ID: 23439622
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study on the effect of Diane and Microgynon 50 contraceptive on the haemostatic mechanisms in Chinese subjects.
    Koh SC; Ratnam SS; Tsakok FH
    Singapore Med J; 1990 Apr; 31(2):116-22. PubMed ID: 2371573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of premature induction of a luteinizing hormone surge with gonadotropin-releasing hormone on ovulation, luteal function, and fertility in cattle.
    Mussard ML; Burke CR; Behlke EJ; Gasser CL; Day ML
    J Anim Sci; 2007 Apr; 85(4):937-43. PubMed ID: 17145968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.